Remgro Full-Year Earnings to Jump Up to 47 Percent
Remgro expects headline earnings per share for the year to June 2026 to rise 37 to 47 percent, ahead of full results on 21 September.
South Africa · MARKETS
Key Facts
- —What happened Remgro told shareholders on 11 September 2026 that full-year headline earnings per share will rise between 37 and 47 percent.
- —The numbers Headline earnings per share for the year ended 30 June 2026 are expected at R19.30 to R20.71 (about US$1.20 to US$1.28), up from R14.09 (about US$0.87) a year earlier.
- —The next date Full results for the year are due on 21 September 2026.
- —The portfolio Remgro holds stakes in Mediclinic, Heineken Beverages, Rainbow Chicken, fibre group CIVH and TotalEnergies Marketing South Africa.
- —Who is in charge Chief Executive Officer Jannie Durand runs the Stellenbosch-based group, while chair Johann Rupert controls the company.
Remgro expects headline earnings per share for the year to June 2026 to rise as much as 47 percent, the Stellenbosch-based investment group said in a trading statement ahead of full results on 21 September.

Remgro full-year earnings are heading for a sharp increase: the investment holding company controlled by billionaire Johann Rupert expects headline earnings per share of between R19.30 and R20.71 (about US$1.10 to US$1.18) for the year ended 30 June 2026. That is 37 to 47 percent more than the R14.09 (about US$0.87) it reported a year earlier, the group said in a trading statement on 11 September 2026.
What the Remgro trading statement says
South African listed companies must warn the market when earnings will move sharply, and Remgro’s notice does exactly that. The expected jump of up to 47 percent in headline earnings per share covers the twelve months to the end of June 2026.
Headline earnings are South Africa’s standard profit measure. They strip out one-off gains and losses such as asset sales, giving a cleaner view of how the underlying businesses are performing. Remgro said the increase was driven by stronger operational performances across key investee companies plus material once-off items; adjusting for those once-off items, headline earnings are expected to rise between 24 and 34 percent. Rand figures in this article are converted at 16.15 per US dollar, the rate of 11 September 2026 (Yahoo Finance).
The full picture, including the dividend and the contribution of each portfolio company, arrives with the annual results on 21 September 2026.
What sits inside Remgro
Remgro is not a single business but a collection of stakes in household names. Its portfolio includes hospital group Mediclinic, Heineken Beverages, poultry producer Rainbow Chicken, fibre infrastructure group CIVH and TotalEnergies Marketing South Africa.
The group also gained from the completion of the Vodacom–Maziv transaction in December 2025, which delivered Remgro a R2.66 billion (about US$165 million) pre-implementation dividend in the first half of the financial year.
Because Remgro owns pieces of many businesses rather than running one, its earnings rise and fall with the combined performance of the portfolio. A jump of this size points to broad improvement across its holdings.
Why it matters beyond one company
Remgro is often read as a barometer of South Africa’s consumer economy. Its stakes in healthcare, food, beverages and fuel retailing mean its results track how ordinary South Africans are spending.
A strong year at Remgro suggests that parts of the domestic economy held up better than the country’s low headline growth would imply. That matters for investors deciding whether South African assets are worth the risk.
The group’s performance also feeds the wider debate about South Africa’s conglomerate model, where holding companies often trade below the value of what they own. Rising earnings give Remgro ammunition against that discount, a theme that runs through Africa: The New Scramble coverage of the continent’s big capital players.
Who gains and who loses
Shareholders gain most directly. Higher headline earnings usually translate into a higher dividend, and Remgro’s interim dividend for this financial year already rose sharply.
Chief Executive Officer Jannie Durand and his team get vindication for a hands-on approach to the portfolio. Chair Johann Rupert, whose family interests control the group, sees the value of a long-held strategy confirmed.
Rival investment holding companies face a tougher comparison. If Remgro keeps delivering earnings growth of this size, pressure rises on peers to show similar discipline.
What to watch next
The key date is 21 September 2026, when Remgro publishes its full results. Investors will look at which portfolio companies drove the increase and what dividend the board declares.
Watch for detail on the fibre business CIVH and the integration of Maziv with Vodacom, as well as any update on Mediclinic’s international operations.
The share price reaction will show whether the market believes the earnings jump is repeatable or a one-off helped by special items such as the Maziv dividend.
Frequently Asked Questions
What did Remgro announce in September 2026?
Remgro issued a trading statement on 11 September 2026 saying headline earnings per share for the year ended 30 June 2026 should rise between 37 and 47 percent.
How much will Remgro earn per share?
The group expects headline earnings per share of R19.30 to R20.71 (about US$1.20 to US$1.28), up from R14.09 (about US$0.87) the previous year.
When are Remgro’s full results due?
Remgro publishes its full results for the year ended 30 June 2026 on 21 September 2026.
Connected Coverage
Sources
This article was produced by The Rio Times’ automated newsroom system. How we use AI · Report an error
LatAm Markets: Live Signals → — real-time movers, turnover leaders and FX across Latin America.